1. Synthetic Biology Market Overview
2. Executive Summary
3. Synthetic Biology Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User profiling
3.2.3. Patent Analysis
3.2.3. Top 5 Financials Analysis
4. Synthetic Biology Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Synthetic Biology Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Synthetic Biology Market – Strategic Analysis
5.1. Synthetic Biology Market - Value Chain Analysis
5.2. Pricing Analysis
5.3. Product/Market Life Cycle Analysis
5.4. Suppliers and Distributors
5.5. Opportunities Analysis.
6. Synthetic Biology Market – By Tools
6.1. Introduction
6.2. Xeno-Nucleic Acid
6.3. Chassis Organism
6.4. Oligonucleotides
6.5. Cloning Technology Kits
6.6. Enzymes
6.7. Synthetic DNA
6.8. Synthetic Genes
6.9. Synthetic Cells
7. Synthetic Biology Market – By Technology
7.1. Introduction
7.2. DNA Synthesis
7.3. DNA Sequencing
7.4. Computational Modelling
7.5. Bioinformatics Technology
7.6. Microfluidics Technology
7.7. Nanotechnology
7.8. Pathway Engineering
7.9. Modular Protein Assembly
7.10. Synthetic Microbial Consortia
7.11. Genome Engineering
7.12. Integrated System
8. Synthetic Biology Market – By Application
8.1. Introduction
8.2. Environmental Application
8.2.1. Bioremediation
8.2.1.1. In-Situ
8.2.1.2. Ex-Situ
8.2.1.2.1. Slurry-Phase
8.2.1.2.2. Solid-Phase
8.2.1. Whole-Cell Biosensors
8.3. Medical Application
8.3.1. Drug Discovery and Therapeutics
8.3.1.1. Gene Circuits
8.3.1.2. Delivery Platform
8.3.1.3. Cancer Detection/Diagnostic
8.3.2. Pharmaceuticals
8.3.3. Artificial Tissue and Regeneration
8.3.3.1. Bio-synthesis
8.3.3.2. Scaffold Synthesis
8.3.3.3. Stem Cell Regulation
8.3.3.4. Cell Programming
8.4. Industrial Application
8.4.1. Biofuel and Renewable Energy
8.4.2. Industrial Enzyme
8.4.2.1. Textile Industry
8.4.2.1.1. Cellulase
8.4.2.1.2. Catalase
8.4.2.1.3. Pectinase
8.4.2.1.4. Alpha Amylase
8.4.2.2. Food & Beverages
8.4.2.2.1. Fungal alpha Amylase
8.4.2.2.2. Glucoamylase
8.4.2.2.3. Papain enzymes
8.4.2.2.4. Beta glucanse
8.4.2.2.5. Protease
8.4.2.3. Paper Industry
8.4.2.3.1. Lipases
8.4.2.3.2. Xylanase
8.4.2.4. Personal Care
8.4.2.4.1. Carbohydrase
8.4.2.4.2. Isomerase
8.4.2.4.3. Zymase
8.4.3. Biomaterials & Green Chemicals
8.4.3.1. Lactic Acid
8.4.3.2. FDCA
8.4.3.3. Succinic Acid
8.4.3.4. Acrylic Acid
8.4.3.5. 1, 3 Propanediol
8.4.3.6. Adipic Acid
8.4.3.7. Castor-based Chemicals
9. Synthetic Biology Market - By Geography
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Ecuador Mexico
9.1.4. Rest of North America
9.2. South America
9.2.1. Brazil
9.2.2. Venezuela
9.2.3. Argentina
9.2.4. Ecuador
9.2.5. Peru
9.2.6. Colombia
9.2.7. Costa Rica
9.2.8. Rest of South America
9.3. Europe
9.3.1. U.K
9.3.2. Germany
9.3.3. Italy
9.3.4. France
9.3.5. Netherlands
9.3.6. Belgium
9.3.7. Spain
9.3.8. Denmark
9.3.9. Rest of Europe
9.4. APAC
9.4.1. China
9.4.2. Australia
9.4.3. South Korea
9.4.4. India
9.4.5. Taiwan
9.4.6. Malaysia
9.4.7. Hong Kong
9.4.8. Japan
9.4.9. Rest of APAC
9.5. Middle East& Africa
9.5.1. Israel
9.5.2. South Africa
9.5.3. Saudi Arabia
9.6. Rest of Middle East and Africa
10. Market Entropy
10.1. New Product Launches
10.2. M&As, Collaborations, JVs, Partnership
11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
11.1. Ingenza Ltd.
11.2. Intrexon Corp.
11.3. Amyris Inc.
11.4. Thermo Fisher Scientific Inc.
11.5. Novozymes
11.6. Cargill Inc.
11.7. Company 7
11.8. Company 8
11.9. Company 9
11.10. Company 10
11.11. Company 11
*More than 9 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
12.Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer